Table 4.
Impact | Smear Microscopy Strategya | Concentrated Xpert Strategyb | Direct Xpert Strategyc |
---|---|---|---|
Time to result, h, median (IQR) | 66 (58–85) | 34 (28–53) | 4.5 (2.9–10) |
Time savings vs microscopy, h, median (IQR)d | … | 35 (24–36) | 45 (35–46) |
Total time in isolation, days/y (95% CI) | 840 (116–1564) | 684 (0–1410) | 35 (31–39) |
Total time savings vs control, days/y (95% CI) | … | 159 (75–242) | 258 (227–288) |
Abbreviations: AFB, acid-fast bacilli; CI, confidence interval; IQR, interquartile range; smear, AFB smear microscopy; Xpert, GeneXpert MTB/RIF assay.
a Collection of 2 sputum samples on separate days for N-acetyl-l-cysteine–sodium hydroxide (NALC-NaOH) concentrated acid-fast bacilli smear microscopy.
b Collection of 1 sputum sample for processing using NALC-NaOH concentration and testing by Xpert.
c Collection of 1 sputum sample for direct testing by Xpert.
d Savings reflect within-patient differences and are not equal to differences between medians for each strategy.